Stroke Therapeutics Market Insights, Global Outlook and Forecast 2022-2028
Stroke Therapeutics Market Insights, Global Outlook and Forecast 2022-2028
Insights into the Stroke Therapeutics Market include supply chain optimization, Stroke Therapeutics challenges, and growth forecasts segmented by region and service type.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The latest research study released by Market IntelliX evaluates market size and forecasts of Stroke Therapeutics in Global, including the following market information:
Global Stroke Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Stroke Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Intravenous Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Stroke Therapeutics include Abbott Laboratories, Cordis, Boston Scientific, Siemens, Genentech, Koninklijke Philips, Medtronic, GE Healthcare and Stryker, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Stroke Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Stroke Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Stroke Therapeutics Market Segment Percentages, by Type, 2021 (%)
Intravenous Injection
Oral
Others
Global Stroke Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Stroke Therapeutics Market Segment Percentages, by Application, 2021 (%)
Ischemic Stroke
Hemorrhagic Stroke
Transient Ischemic Attack
Global Stroke Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Stroke Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Stroke Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Stroke Therapeutics revenues share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
Abbott Laboratories
Cordis
Boston Scientific
Siemens
Genentech
Koninklijke Philips
Medtronic
GE Healthcare
Stryker
Merck
Zocere, Inc.
Acticor Biotech
DiaMedica Therapeutics
Lumosa Therapeutics
AXONIS Therapeutics , Inc.
NovaGo Therapeutics
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Stroke Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Stroke Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Stroke Therapeutics Overall Market Size
2.1 Global Stroke Therapeutics Market Size: 2021 VS 2028
2.2 Global Stroke Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Stroke Therapeutics Players in Global Market
3.2 Top Global Stroke Therapeutics Companies Ranked by Revenue
3.3 Global Stroke Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Stroke Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Stroke Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Stroke Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Stroke Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Stroke Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Stroke Therapeutics Market Size Markets, 2021 & 2028
4.1.2 Intravenous Injection
4.1.3 Oral
4.1.4 Others
4.2 By Type - Global Stroke Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Stroke Therapeutics Revenue, 2017-2022
4.2.2 By Type - Global Stroke Therapeutics Revenue, 2023-2028
4.2.3 By Type - Global Stroke Therapeutics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Stroke Therapeutics Market Size, 2021 & 2028
5.1.2 Ischemic Stroke
5.1.3 Hemorrhagic Stroke
5.1.4 Transient Ischemic Attack
5.2 By Application - Global Stroke Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Stroke Therapeutics Revenue, 2017-2022
5.2.2 By Application - Global Stroke Therapeutics Revenue, 2023-2028
5.2.3 By Application - Global Stroke Therapeutics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Stroke Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Stroke Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Stroke Therapeutics Revenue, 2017-2022
6.2.2 By Region - Global Stroke Therapeutics Revenue, 2023-2028
6.2.3 By Region - Global Stroke Therapeutics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Stroke Therapeutics Revenue, 2017-2028
6.3.2 US Stroke Therapeutics Market Size, 2017-2028
6.3.3 Canada Stroke Therapeutics Market Size, 2017-2028
6.3.4 Mexico Stroke Therapeutics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Stroke Therapeutics Revenue, 2017-2028
6.4.2 Germany Stroke Therapeutics Market Size, 2017-2028
6.4.3 France Stroke Therapeutics Market Size, 2017-2028
6.4.4 U.K. Stroke Therapeutics Market Size, 2017-2028
6.4.5 Italy Stroke Therapeutics Market Size, 2017-2028
6.4.6 Russia Stroke Therapeutics Market Size, 2017-2028
6.4.7 Nordic Countries Stroke Therapeutics Market Size, 2017-2028
6.4.8 Benelux Stroke Therapeutics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Stroke Therapeutics Revenue, 2017-2028
6.5.2 China Stroke Therapeutics Market Size, 2017-2028
6.5.3 Japan Stroke Therapeutics Market Size, 2017-2028
6.5.4 South Korea Stroke Therapeutics Market Size, 2017-2028
6.5.5 Southeast Asia Stroke Therapeutics Market Size, 2017-2028
6.5.6 India Stroke Therapeutics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Stroke Therapeutics Revenue, 2017-2028
6.6.2 Brazil Stroke Therapeutics Market Size, 2017-2028
6.6.3 Argentina Stroke Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Stroke Therapeutics Revenue, 2017-2028
6.7.2 Turkey Stroke Therapeutics Market Size, 2017-2028
6.7.3 Israel Stroke Therapeutics Market Size, 2017-2028
6.7.4 Saudi Arabia Stroke Therapeutics Market Size, 2017-2028
6.7.5 UAE Stroke Therapeutics Market Size, 2017-2028
7 Players Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Corporate Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Stroke Therapeutics Major Product Offerings
7.1.4 Abbott Laboratories Stroke Therapeutics Revenue in Global Market (2017-2022)
7.1.5 Abbott Laboratories Key News
7.2 Cordis
7.2.1 Cordis Corporate Summary
7.2.2 Cordis Business Overview
7.2.3 Cordis Stroke Therapeutics Major Product Offerings
7.2.4 Cordis Stroke Therapeutics Revenue in Global Market (2017-2022)
7.2.5 Cordis Key News
7.3 Boston Scientific
7.3.1 Boston Scientific Corporate Summary
7.3.2 Boston Scientific Business Overview
7.3.3 Boston Scientific Stroke Therapeutics Major Product Offerings
7.3.4 Boston Scientific Stroke Therapeutics Revenue in Global Market (2017-2022)
7.3.5 Boston Scientific Key News
7.4 Siemens
7.4.1 Siemens Corporate Summary
7.4.2 Siemens Business Overview
7.4.3 Siemens Stroke Therapeutics Major Product Offerings
7.4.4 Siemens Stroke Therapeutics Revenue in Global Market (2017-2022)
7.4.5 Siemens Key News
7.5 Genentech
7.5.1 Genentech Corporate Summary
7.5.2 Genentech Business Overview
7.5.3 Genentech Stroke Therapeutics Major Product Offerings
7.5.4 Genentech Stroke Therapeutics Revenue in Global Market (2017-2022)
7.5.5 Genentech Key News
7.6 Koninklijke Philips
7.6.1 Koninklijke Philips Corporate Summary
7.6.2 Koninklijke Philips Business Overview
7.6.3 Koninklijke Philips Stroke Therapeutics Major Product Offerings
7.6.4 Koninklijke Philips Stroke Therapeutics Revenue in Global Market (2017-2022)
7.6.5 Koninklijke Philips Key News
7.7 Medtronic
7.7.1 Medtronic Corporate Summary
7.7.2 Medtronic Business Overview
7.7.3 Medtronic Stroke Therapeutics Major Product Offerings
7.7.4 Medtronic Stroke Therapeutics Revenue in Global Market (2017-2022)
7.7.5 Medtronic Key News
7.8 GE Healthcare
7.8.1 GE Healthcare Corporate Summary
7.8.2 GE Healthcare Business Overview
7.8.3 GE Healthcare Stroke Therapeutics Major Product Offerings
7.8.4 GE Healthcare Stroke Therapeutics Revenue in Global Market (2017-2022)
7.8.5 GE Healthcare Key News
7.9 Stryker
7.9.1 Stryker Corporate Summary
7.9.2 Stryker Business Overview
7.9.3 Stryker Stroke Therapeutics Major Product Offerings
7.9.4 Stryker Stroke Therapeutics Revenue in Global Market (2017-2022)
7.9.5 Stryker Key News
7.10 Merck
7.10.1 Merck Corporate Summary
7.10.2 Merck Business Overview
7.10.3 Merck Stroke Therapeutics Major Product Offerings
7.10.4 Merck Stroke Therapeutics Revenue in Global Market (2017-2022)
7.10.5 Merck Key News
7.11 Zocere, Inc.
7.11.1 Zocere, Inc. Corporate Summary
7.11.2 Zocere, Inc. Business Overview
7.11.3 Zocere, Inc. Stroke Therapeutics Major Product Offerings
7.11.4 Zocere, Inc. Stroke Therapeutics Revenue in Global Market (2017-2022)
7.11.5 Zocere, Inc. Key News
7.12 Acticor Biotech
7.12.1 Acticor Biotech Corporate Summary
7.12.2 Acticor Biotech Business Overview
7.12.3 Acticor Biotech Stroke Therapeutics Major Product Offerings
7.12.4 Acticor Biotech Stroke Therapeutics Revenue in Global Market (2017-2022)
7.12.5 Acticor Biotech Key News
7.13 DiaMedica Therapeutics
7.13.1 DiaMedica Therapeutics Corporate Summary
7.13.2 DiaMedica Therapeutics Business Overview
7.13.3 DiaMedica Therapeutics Stroke Therapeutics Major Product Offerings
7.13.4 DiaMedica Therapeutics Stroke Therapeutics Revenue in Global Market (2017-2022)
7.13.5 DiaMedica Therapeutics Key News
7.14 Lumosa Therapeutics
7.14.1 Lumosa Therapeutics Corporate Summary
7.14.2 Lumosa Therapeutics Business Overview
7.14.3 Lumosa Therapeutics Stroke Therapeutics Major Product Offerings
7.14.4 Lumosa Therapeutics Stroke Therapeutics Revenue in Global Market (2017-2022)
7.14.5 Lumosa Therapeutics Key News
7.15 AXONIS Therapeutics , Inc.
7.15.1 AXONIS Therapeutics , Inc. Corporate Summary
7.15.2 AXONIS Therapeutics , Inc. Business Overview
7.15.3 AXONIS Therapeutics , Inc. Stroke Therapeutics Major Product Offerings
7.15.4 AXONIS Therapeutics , Inc. Stroke Therapeutics Revenue in Global Market (2017-2022)
7.15.5 AXONIS Therapeutics , Inc. Key News
7.16 NovaGo Therapeutics
7.16.1 NovaGo Therapeutics Corporate Summary
7.16.2 NovaGo Therapeutics Business Overview
7.16.3 NovaGo Therapeutics Stroke Therapeutics Major Product Offerings
7.16.4 NovaGo Therapeutics Stroke Therapeutics Revenue in Global Market (2017-2022)
7.16.5 NovaGo Therapeutics Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Stroke Therapeutics Market Opportunities & Trends in Global Market
Table 2. Stroke Therapeutics Market Drivers in Global Market
Table 3. Stroke Therapeutics Market Restraints in Global Market
Table 4. Key Players of Stroke Therapeutics in Global Market
Table 5. Top Stroke Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Stroke Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Stroke Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Stroke Therapeutics Product Type
Table 9. List of Global Tier 1 Stroke Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Stroke Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Stroke Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Stroke Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Stroke Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Stroke Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Stroke Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Stroke Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Stroke Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Stroke Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Stroke Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Stroke Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Stroke Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Stroke Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Stroke Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Stroke Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Stroke Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Stroke Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Stroke Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Stroke Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Stroke Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Laboratories Corporate Summary
Table 31. Abbott Laboratories Stroke Therapeutics Product Offerings
Table 32. Abbott Laboratories Stroke Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Cordis Corporate Summary
Table 34. Cordis Stroke Therapeutics Product Offerings
Table 35. Cordis Stroke Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Boston Scientific Corporate Summary
Table 37. Boston Scientific Stroke Therapeutics Product Offerings
Table 38. Boston Scientific Stroke Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Siemens Corporate Summary
Table 40. Siemens Stroke Therapeutics Product Offerings
Table 41. Siemens Stroke Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Genentech Corporate Summary
Table 43. Genentech Stroke Therapeutics Product Offerings
Table 44. Genentech Stroke Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Koninklijke Philips Corporate Summary
Table 46. Koninklijke Philips Stroke Therapeutics Product Offerings
Table 47. Koninklijke Philips Stroke Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Medtronic Corporate Summary
Table 49. Medtronic Stroke Therapeutics Product Offerings
Table 50. Medtronic Stroke Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. GE Healthcare Corporate Summary
Table 52. GE Healthcare Stroke Therapeutics Product Offerings
Table 53. GE Healthcare Stroke Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Stryker Corporate Summary
Table 55. Stryker Stroke Therapeutics Product Offerings
Table 56. Stryker Stroke Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. Merck Corporate Summary
Table 58. Merck Stroke Therapeutics Product Offerings
Table 59. Merck Stroke Therapeutics Revenue (US$, Mn), (2017-2022)
Table 60. Zocere, Inc. Corporate Summary
Table 61. Zocere, Inc. Stroke Therapeutics Product Offerings
Table 62. Zocere, Inc. Stroke Therapeutics Revenue (US$, Mn), (2017-2022)
Table 63. Acticor Biotech Corporate Summary
Table 64. Acticor Biotech Stroke Therapeutics Product Offerings
Table 65. Acticor Biotech Stroke Therapeutics Revenue (US$, Mn), (2017-2022)
Table 66. DiaMedica Therapeutics Corporate Summary
Table 67. DiaMedica Therapeutics Stroke Therapeutics Product Offerings
Table 68. DiaMedica Therapeutics Stroke Therapeutics Revenue (US$, Mn), (2017-2022)
Table 69. Lumosa Therapeutics Corporate Summary
Table 70. Lumosa Therapeutics Stroke Therapeutics Product Offerings
Table 71. Lumosa Therapeutics Stroke Therapeutics Revenue (US$, Mn), (2017-2022)
Table 72. AXONIS Therapeutics , Inc. Corporate Summary
Table 73. AXONIS Therapeutics , Inc. Stroke Therapeutics Product Offerings
Table 74. AXONIS Therapeutics , Inc. Stroke Therapeutics Revenue (US$, Mn), (2017-2022)
Table 75. NovaGo Therapeutics Corporate Summary
Table 76. NovaGo Therapeutics Stroke Therapeutics Product Offerings
Table 77. NovaGo Therapeutics Stroke Therapeutics Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Stroke Therapeutics Segment by Type in 2021
Figure 2. Stroke Therapeutics Segment by Application in 2021
Figure 3. Global Stroke Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Stroke Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Stroke Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Stroke Therapeutics Revenue in 2021
Figure 8. By Type - Global Stroke Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Stroke Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Stroke Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Stroke Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Stroke Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Stroke Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Stroke Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Stroke Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Stroke Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Stroke Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Stroke Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Stroke Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Stroke Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Stroke Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Stroke Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Stroke Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Stroke Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Stroke Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Stroke Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Stroke Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Stroke Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Stroke Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Stroke Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Stroke Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Stroke Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Stroke Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Stroke Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Stroke Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Stroke Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Laboratories Stroke Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Cordis Stroke Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Boston Scientific Stroke Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Siemens Stroke Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Genentech Stroke Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Koninklijke Philips Stroke Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Medtronic Stroke Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. GE Healthcare Stroke Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Stryker Stroke Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Merck Stroke Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Zocere, Inc. Stroke Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Acticor Biotech Stroke Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. DiaMedica Therapeutics Stroke Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Lumosa Therapeutics Stroke Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. AXONIS Therapeutics , Inc. Stroke Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. NovaGo Therapeutics Stroke Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Research Methodology:
Stroke Therapeutics Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|